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Abstract
Mice lacking the Abc4 protein encoded by the multidrug resistance-2 gene (Mdr2
2/2) develop chronic periductular
inflammation and cholestatic liver disease resulting in the development of hepatocellular carcinoma (HCC).Inhibition of NF-kB
by expression of an IkBa super-repressor (IkBaSR) transgene in hepatocytes was shown to prevent HCC development in
Mdr2
2/2 mice, suggesting that NF-kB acts as a tumour promoter in this model of inflammation-associated carcinogenesis. On
the other hand, inhibition of NF-kB by hepatocyte specific ablation of IKK2 resulted in increased liver tumour development
induced by the chemical carcinogen DEN. To address the role of IKK2-mediated NF-kB activation in hepatocytes in the
pathogenesis of liver disease and HCC in Mdr2
2/2 mice, we generated Mdr2-deficient animals lacking IKK2 specifically in
hepatocytes using the Cre-loxP system. Mdr2
2/2 mice lacking IKK2 in hepatocytes developed spontaneously a severe liver
disease characterized by cholestasis, major hyperbilirubinemia and severe to end-stage fibrosis, which caused muscle wasting,
loss of body weight, lethargy and early spontaneous death. Cell culture experiments showed that primary hepatocytes lacking
IKK2 were more sensitive to bile acid induced death, suggesting that hepatocyte-specific IKK2 deficiency sensitized
hepatocytes tothetoxicity of bile acids under conditionsof cholestasis resultingingreatly exacerbated liverdamage.Mdr2
2/2
IKK2
Hep-KOmice remarkably recapitulatechronic liver failurein humans andmight beof specialimportance forthestudy of the
mechanisms contributing to the pathogenesis of end-stage chronic liver disease or its implications on other organs.
Conclusion: IKK2-mediated signalingin hepatocytes protects the liver from damageunder conditions of chronicinflammatory
cholestasis and prevents the development of severe fibrosis and liver failure.
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Introduction
In humans, liver fibrosis is caused by a variety of different
diseases such as chronic viral hepatitis, autoimmune liver disease
and other disorders characterized by chronic liver inflammation
[1]. Although the quality of the fibrosis may be different
depending on the underlying pathology, in all cases fibrosis is
caused by the activation of specialized stellate cells, which
differentiate into active myofibroblasts that remodel the extracel-
lular matrix of the liver [2], [3]. Under normal conditions
myofibroblasts reside in a quiescent state and need to become
stimulated in order to proliferate and differentiate into motile
collagen-producing cells. In humans, almost all patients with
chronic liver injury will develop fibrosis, which in many individuals
will ultimately result in liver cirrhosis and end-stage liver disease, a
condition that has a high morbidity and mortality and is discussed
to favor initiation and progression of hepatocellular carcinoma [4].
Therefore, there is an urgent need to study the molecular and
cellular mechanisms by which inflammatory signals regulate
myofibroblast activation in order to better understand the
mechanisms that control the pathogenesis of liver fibrosis and its
detrimental consequences.
The multidrug resistance-2 knockout (Mdr2
2/2) mouse provides a
model for the study of liver fibrosis and hepatocarcinogenesis in the
context of chronic inflammation. In contrast to other multidrug
resistance proteins of the Mdr family, Mdr2 does not facilitate
resistance towards specific chemicals (as for human Mdr1) by directly
shuttling metabolites out of the cell [5]. Instead, studies in Mdr2
2/2
mice suggest that Mdr2 mediates the flipping of phospholipids
(phosphatidylcholine) from the cytosol of the hepatocyte into the bile
canaliculi [5]. Phospholipids are thought to potently emulsify
hydrophobic molecules such as certain bile acids and thereby
attenuate their toxicity. Although the mechanisms controlling the
pathogenesis of liver disease in Mdr2
2/2 mice are still under
discussion, several studies have demonstrated that mice lacking Mdr2
develop a chronic inflammatory liver condition,whichischaracterized
by periductular inflammatory cell infiltration and periportal fibrosis
typically bridging adjacent portal fields [6], [7], [8].
. Additionally, in
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e25942the FVB/N genetic background, 100% of Mdr2 deficient mice
develop hepatocellular carcinoma at the age of 16 months [8].
The transcription factor Nuclear Factor kappa B (NF-kB) regulates
immune and inflammatory responses by controlling the expression of
genes withimportant immunoregulatoryfunctions.In resting cells NF-
kB dimers are sequestered in the cytoplasm by association with
inhibitory proteins belonging to the IkB family. When the cell is
activated by a variety of stress-inducing stimuli, the IkBk i n a s e
complex (IKK), consisting of two catalytic subunits, IKK1 (or IKKa)
and IKK2 (or IKKb) and a regulatory subunit named NEMO (or
IKKc), phosphorylates IkBs on specific serine residues triggering their
polyubiquitination and degradation through the proteasome. Conse-
quently, NF-kB homo- and heterodimers are set free and translocate
into the nucleus where they transactivate target genes, among them
survival factors and inflammatory mediators [9], [10]. NF-kBi s
activated by a large number of stress-inducing stimuli, including
cytokines, microbial products and conditions that impose threat on the
cell such as radiation, hypoxia, mechanical stress [9]. With particular
relevance to bile duct disease, cytotoxic bile acids are also potent
activators of the NF-kB pathway [11], [12].
Studies in genetic mouse models revealed important functions of
the IKK/NF-kB pathway in the regulation of liver physiology and
the pathogenesis of liver diseases [9]. Mice lacking NEMO in liver
parenchymal cells spontaneously develop chronic liver disease due
to increased death of NEMO-deficient hepatocytes, which triggers
liver inflammation and compensatory hepatocyte proliferation
resulting in hepatocellular carcinoma (HCC) [13]. In addition,
IKK2 has been shown to protect mice from chemically induced
liver cancer mainly by inhibiting carcinogen-induced hepatocyte
death and preventing compensatory proliferation of hepatocytes
[14]. Moreover, recent studies showed that mice lacking both IKK1
and IKK2 in liver parenchymal cells develop severe jaundice and
fatal cholangitis, demonstrating that IKK1 and IKK2 cooperate to
maintain the integrity of the small bile ducts in the liver.
Importantly, ablation of solely NEMO, IKK1 or IKK2 could not
provoke this phenotype [15], indicating that the individual IKK
subunits show a degree of functional redundancy in the liver.
NF-kB inhibition in hepatocytes by expression of an IkB super-
repressor (IkBaSR) transgene did not affect liver inflammation in
Mdr2
2/2 mice but strongly reduced the development of
hepatocellular carcinoma, suggesting that NF-kB activation
promotes the survival of premalignant cells facilitating liver cancer
development in this model [7]. To unveil the role of IKK2 in liver
cancer development in Mdr2
2/2 mice, we generated and
analyzed Mdr2
2/2 animals that lack IKK2 expression specifically
in hepatocytes (Mdr2
2/2IKK2
Hep-KO). Surprisingly, we found
that hepatocyte-specific deletion of IKK2 severely aggravated liver
pathology of Mdr2
2/2 mice. Mdr2
2/2IKK2
Hep-KO mice devel-
oped severe jaundice at young age and failed to thrive remaining
considerably smaller compared to their wild-type or Mdr2
2/2
littermates. In addition, Mdr2
2/2IKK2
Hep-KO mice developed
severe liver fibrosis accompanied by massive bile duct proliferation
as compared to Mdr2
2/2 mice. Finally, we show that IKK2
deficient hepatocytes were more sensitive to bile acid induced
cytotoxicity, suggesting that IKK2 signaling has an important
function to protect hepatocytes from bile acid toxicity and prevent
severe liver damage in conditions of primary biliary disease.
Results
Mdr2
2/2IKK2
Hep-KO mice develop severe wasting due to
liver disease
To study the hepatocyte-specific role of IKK2 mediated NF-kB
activation in liver disease and cancer induced by Mdr2 deficiency,
we crossed Mdr2
2/2 mice with mice carrying loxP-flanked IKK2
alleles [16] and the Albumin-Cre transgene [17]. These double
Mdr2
2/2IKK2
Hep-KO mice lack Mdr2 expression in all cells and
additionally have a hepatocyte-specific ablation of IKK2 (Fig. 1A).
Mdr2
2/2IKK2
Hep-KO mice were born at the expected Mendelian
ratio but were already distinguishable from their littermates in the
first two weeks of life as they were considerably smaller. Although
Mdr2
2/2IKK2
Hep-KO mice showed an initial phase of growth till
they reached 4 weeks of age, they subsequently lost about 30% of
their body weight and at the age of 8 weeks weighed 50% less
compared to their heterozygous Mdr2
+/2IKK2
Hep-KO but also
single Mdr2
2/2 littermates (Fig. 1B, 1C). These results suggested
that Mdr2
2/2IKK2
Hep-KO mice suffer from liver disease resulting
in poor growth and prompted us to investigate in detail the liver
function in these animals.
Mdr2
2/2IKK2
Hep-KO mice appeared severely jaundiced and their
limbs and trunk showed varying degrees of muscle wasting and loss of
fat mass (Fig. 1C). Necropsy of Mdr2
2/2,M d r 2
+/2IKK2
Hep-KO and
Mdr2
2/2IKK2
Hep-KO mice confirmed major jaundice of organs and
serosae and substantial loss of body fat (Fig. 1D) only in the double
knockout animals. The livers of Mdr2
2/2IKK2
Hep-KO mice appeared
yellow - green tainted and were harder to cut compared to the livers of
Mdr2
2/2 or Mdr2
+/2IKK2
Hep-KO m i c e( F i g .1 D ) .M d r 2
2/2
IKK2
Hep-KO mice also showed massively enlarged gallbladders that
were filled with bile (Fig. 1D). In contrast, single Mdr2
2/2 and
heterozygous Mdr2
+/2IKK2
Hep-KO mice were indistinguishable from
wild type mice (Fig. 1C, 1D) arguing that the lack of IKK2 in
hepatocytes only culminates in the observed phenotype when Mdr2 is
completely absent.
Mdr2
2/2IKK2
Hep-KO mice show increased liver damage
To further characterize the liver disease developing in Mdr2
2/2
IKK2
Hep-KO mice we measured the levels of serum alanine amino
transferase (ALT) in young adult mice (aged 2–6 months). We could
not analyze a statistically meaningful number of mice in older age as
most Mdr2
2/2IKK2
Hep-KO mice died or showed very severe disease
and had to be sacrificed before the age of 30 weeks. We found that
Mdr2
2/2IKK2
Hep-KO mice had about six-fold elevated serum ALT
levels compared to their control littermates, indicating that these
animals showed increased spontaneous liver damage (Fig. 2A). At this
age, Mdr2
2/2 mice did not show elevated serum ALT levels
compared to heterozygous Mdr2
+/2IKK2
Hep-KO mice. In line with
the increased ALT levels, we found that liver sections from Mdr2
2/2
IKK2
Hep-KO mice contained increased numbers of dying hepatocytes
as compared to Mdr2
2/2 mice or Mdr2
+/2IKK2
Hep-KO mice
( F i g .2 D ) .I na d d i t i o n ,l i v e rs e c t i o n sf r o mM d r 2
2/2IKK2
Hep-KO also
showed more PCNA positive cells in comparison to Mdr2
2/2 mice or
Mdr2
+/2IKK2
Hep-KO mice indicating a higher level of compensatory
proliferation (Fig. 2E). The observation that Mdr2
2/2IKK2
Hep-KO
mice were severely jaundiced prompted us to further investigate
potential bile duct related complications. We therefore measured the
levels of serum Alkaline Phosphatase (AP), a widely used marker
for bile flow obstruction [18], in Mdr2
2/2IKK2
Hep-KO and their
control littermates. Indeed, serum AP levels were massively
elevated in Mdr2
2/2IKK2
Hep-KO mice compared to either
Mdr2
2/2 or Mdr2
+/2IKK2
Hep-KO littermates (Fig. 2B). Additionally,
Mdr2
2/2IKK2
Hep-KO mice showed strongly elevated levels of total
bilirubin in the serum compared to their littermate controls (Fig. 2C).
These results suggest that Mdr2
2/2IKK2
Hep-KO mice suffer from
obstructive biliary disease. Mdr2
2/2 mice showed slightly elevated AP
levels compared to heterozygous Mdr2
+/2IKK2
Hep-KO mice but the
levels of bilirubin were within the normal range in both control groups.
Collectively, these results showed that Mdr2
2/2IKK2
Hep-KO mice
Role of IKK2 in Mdr2
2/2 Mice
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2/2IKK2
Hep-KO mice show impaired growth and signs of jaundice. (A) Immunoblot of whole liver lysates from 3
representative mice for each depicted genotype. Tubulin serves as loading control. (B) Weight curve of male mice for the denoted genotypes.
*p ,0,05 for Mdr2
+/2 IKK2
Hep-KO vs. Mdr2
2/2,* *p ,0,001 for Mdr2
2/2 IKK2
Hep-KO vs. Mdr2
2/2. (C) Macroscopic appearance of littermate male mice at
12 weeks of age. Genotypes as specified in the picture. (D) Necropsy of littermate mice from (C). White arrowheads: enlarged gall bladder in double
knockout mouse. Black arrowhead: jaundiced peritoneal serosa in double knockout mouse vs. normal appearance of serosa in Mdr2
2/2 and Mdr2
+/2
IKK2
Hep-KO mice. The ruler indicates centimeters in C and D.
doi:10.1371/journal.pone.0025942.g001
Role of IKK2 in Mdr2
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PLoS ONE | www.plosone.org 3 October 2011 | Volume 6 | Issue 10 | e25942spontaneously developed an obstructive bile duct-related disease
resulting in liver damage and severe jaundice.
Increased cholangiocyte proliferation and severe liver
fibrosis in Mdr2
2/2IKK2
Hep-KO mice
To further characterize the liver pathology developing in
Mdr2
2/2IKK2
Hep-KO mice we performed immunohistochemical
analysis of liver sections from these animals and from littermate
controls. Consistent with previous reports [6], [8], [7], the livers of
Mdr2
2/2 mice showed immune cell infiltration around the bile
ducts already at young age, which was more pronounced in older
animals (Fig. 3A). Analysis of liver sections from Mdr2
2/2
IKK2
Hep-KO mice showed a more severe pathology with strong
immune cell infiltration in the portal areas and massive expansion
of the bile ducts in older animals (Fig. 3A). Immunostaining for
cytokeratin 19, a marker of bile duct epithelial cells in the liver,
revealed that Mdr2
2/2IKK2
Hep-KO mice showed more pro-
nounced expansion and hyperproliferation of biliary epithelial cells
Figure 2. Mdr2
2/2IKK2
Hep-KO mice exhibit increased liver damage, hepatocyte death and cholestasis. (A) Alanine aminotransferase
(ALT), (B) alkaline phosphatase (AP), and (C) bilirubin levels in serum of adult male mice (8–26 weeks) with the indicated genotypes. Error bars indicate
SEM. Number of mice: Mdr2
2/2IKK2
Hep2KO: n=10, Mdr2
2/2: n=7, Mdr2
+/2IKK2
Hep-KO: n=7 and Mdr2
+/+IKK2
FL: n=2. (D–E) Representative pictures of
TUNEL (D) and PCNA staining (E) on sections of paraffin-embedded livers from mice with the indicated genotypes. The green signal in E corresponds
to background auto-fluorescence and was used to visualize the general morphology of the liver tissues. Scale bars: 20 mm.
doi:10.1371/journal.pone.0025942.g002
Role of IKK2 in Mdr2
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from Mdr2
2/2 mice presented with hyperproliferating bile ducts
close to or connecting the portal fields (Fig. 3A, 3B), Mdr2
2/2
IKK2
Hep-KO mice had strongly enlarged bile duct lumina and
showed hyperproliferating bile ducts spanning from one portal
field to the next also affecting more central areas (Fig. 3B and 4A).
We did not detect histological signs of pathology in the livers of
heterozygous Mdr2
+/2IKK2
Hep-KO control mice (Fig. 3A and 3B).
The livers from Mdr2
2/2IKK2
Hep-KO mice were hard to
cut, indicating the presence of fibrosis. We therefore stained
liver sections with Masson’s trichrome and with Sirius red to
visualize fibrotic areas. As reported previously, livers from
Mdr2
2/2 mice showed bridging fibrosis with connective tissue
fibers concentrating in the periportal and periductular area as
shown by Masson Trichrome and Sirius Red staining (Fig. 4A
and 4B respectively). Interestingly, fibers were more abundant
in the liver of Mdr2
2/2IKK2
Hep-KO mice already at younger
age compared to Mdr2 knockouts, while Mdr2
+/2IKK2
Hep-KO
animals did not show any fibrosis (Fig. 4A and 4B).
Furthermore, already at young age fibrosis in Mdr2
2/2
IKK2
Hep-KO mice followed also a pericellular distribution
(Fig. 4B). This latter pattern of fiber deposition is sometimes
referred to as chicken-wire fibrosis and in humans can help to
distinguish between causes of liver injury [19]. Only in
Mdr2
2/2IKK2
Hep-KO a n i m a l sf i b r o s i sr e a c h e das t a g ew h e r e
macroscopically and microscopically the liver surface became
uneven (data not shown). Quantification of the fibrotic area in
Sirius red stained liver sections revealed that Mdr2
2/2IK-
K2
Hep-KO
mice have significantly more fibrosis as compared to
Mdr2
2/2 and Mdr2
2/2IKK2
Hep-KO mice (Fig. 4C).
Mdr2
2/2 micein the FVB/N genetic background were shown to
spontaneously develop hepatocellular carcinoma with 100%
penetrance by the age of 16 months [8]. Due to the severe
phenotype and early lethality of Mdr2
2/2IKK2
Hep-KO mice we
could not analyze animalsolderthan 9–10monthstoevaluateHCC
development. However, we did not observe any malignant or
premalignant lesions in livers from Mdr2
2/2IKK2
Hep-KO at 2 to 10
months of age. In addition, we could not detect any malignant or
premalignant areas in the livers of Mdr2
2/2 mice up to 14 months
of age (data not shown). These findings are consistent with a recent
report demonstrating that when Mdr2
2/2 mice were crossed into
the C57Bl/6 background tumor development was suppressed [20].
Figure 3. Histological analysis of the liver pathology in Mdr2
2/2IKK2
Hep-KO mice. (A) Representative images of Hematoxylin & Eosin (HE)
stained livers from young (12-week-old) littermate male mice and old (27–30 weeks) mice with the specified genotypes. Insert: High magnification of
corresponding liver sections. (B) Immunofluorescence staining of cytokeratin 19 (CK19) in old male mice. DNA was stained with DAPI. The dashed line
marks the distance from one portal field to the next, showing extreme abundance of CK19 positive cells in the Mdr2
2/2 IKK2
Hep-KO as compared to
Mdr2
2/2 or Mdr2
+/2IKK2
Hep-KO mice. PV portal vein. CV central vein. BD bile duct. Scale bars, 100 mm.
doi:10.1371/journal.pone.0025942.g003
Role of IKK2 in Mdr2
2/2 Mice
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apoptosis
Our results presented above showed that hepatocyte-specific
ablation of IKK2 severely affected liver function in Mdr2-deficient
animals resulting in chronic obstructive bile duct disease, severe
jaundice, liver fibrosis and early death.
Mdr2-deficiency impairs the enrichment of bile with phospho-
lipids, which are important to emulsify and thus reduce the
toxicity of bile acids. Therefore the bile of Mdr2
2/2 mice is more
toxic. We hypothesized that IKK2 ablation in hepatocytes
strongly aggravated the liver pathology of Mdr2-deficient mice
by sensitizing hepatocytes to bile acid toxicity. Indeed, bile acids
have been shown to activate the NF-kB pathway in obstructive
cholestasis suggesting that NF-kB might have a protective
function in cholestatic liver disease, although the exact mecha-
nism remains poorly understood [12]. It has been shown that
hydrophobic bile acids can induce apoptosis in primary cultured
hepatocytes of mouse or rat origin [21]. We therefore chose to
compare the toxicity of glycochenodeoxycholate (GCDC) and
taurolithocholylsulfate (TLCS), both of which have been reported
to induce apoptosis in primary hepatocytes from rat and mouse
[11,12,22,23,24], in wild-type and IKK2-deficient primary
hepatocytes. TLCS treatment of wild-type and IKK2-deficient
primary hepatocytes resulted in markedly increased numbers of
apoptotic/dead cells as revealed after DAPI staining by the
detection of small highly fluorescent nuclei with condensed
chromatin [25] (Fig. 5A). We observed about two-fold increase of
apoptotic/dead cells in the IKK2-deficient as compared to the
wild-type hepatocytes at 12, 24 and 48 hours of stimulation with
TLCS (Fig. 5B). To assess differences in the early apoptotic
response we stimulated wild type and IKK2-deficient primary
mouse hepatocytes with TLCS or GCDC and examined caspase-
3 activation by immunoblotting with antibodies recognizing the
cleaved/active version of caspase-3. These experiments revealed
a stronger and earlier activation of caspase-3 in TLCS and
GCDC stimulated IKK2-deficient primary hepatocytes, suggest-
ing that NF-kB inhibition by ablation of IKK2 sensitized
hepatocytes to bile acid-induced apoptosis (Fig. 5C). Taken
together, these results show that IKK2-mediated signaling
protects primary hepatocytes from the toxicity of hydrophobic
bile acids, suggesting that NF-kB activation in hepatocytes is
critical for the prevention of liver damage in obstructive biliary
disease.
Discussion
In humans, chronic cholestatic liver diseases constitute a major
risk for the development of liver cirrhosis and end-stage liver disease
culminating in liver failure. Obstruction of the bile flow in bile ducts
and bile canaliculi can damage both bile duct epithelial cells and
hepatocytes. Our knowledge about the mechanisms regulating the
cross-talk between hepatocytes and bile duct epithelial cells in the
normal liver and also under conditions of cholestasis remains
limited. The Mdr2 knockout mouse is an excellent model for the
study of chronic inflammatory biliary liver disease, liver fibrosis and
hepatocarcinogenesis. Abc4, the product of the Mdr2 gene, is
expressed in hepatocytes and functions to flip phospholipids into the
bile canaliculi. Phospholipids emulsify hydrophobic bile acids
reducing their toxic effects, therefore enrichment of the bile with
phospholipids is important to reduce bile toxicity. The increased
toxicity of the bile in Mdr2-deficient mice is thought to induce bile
duct inflammation and the liver disease in these animals [6], [5].
Here we show that hepatocyte-specific ablation of IKK2 in the
context of disturbed bile homeostasis induced by Mdr2 deficiency
results in severe cholestatic liver disease in young age, suggesting
that activation of the IKK2/NF-kB pathway in hepatocytes
constitutes an essential regulator of liver function under conditions
of bile duct inflammation.
In older Mdr2
2/2 mice, bile duct inflammation progresses to
fibrosis especially around the periportal area of the liver lobule.
Ultimately, as a result of the chronic inflammation, Mdr2
2/2 mice
in the FVB genetic background develop hepatocellular carcinoma
by the age of 16 months [26]. Mdr2
2/2IKK2
Hep-KO mice showed
more severe bile duct inflammation and biliary epithelial cell
hyperproliferation, and also they presented with more severe
fibrosis in all areas of the liver, i.e. periportal and pericentral areas
compared to Mdr2
2/2 animals. At early stages, Mdr2
2/2
IKK2
Hep-KO mice also showed more prominent fibrosis in the
periportal area as compared to the central area of the liver lobule.
It seems plausible that while in Mdr2
2/2 mice hepatocyte damage
is restrained in the vicinity of the bile ducts, the absence of IKK2
in Mdr2
2/2IKK2
Hep-KO hepatocytes facilitates the extension of
parenchymal damage spreading into more centrally located areas
of the liver lobule. Our experiments showing that IKK2-deficient
primary hepatocytes were more sensitive to apoptosis induced
by hydrophobic bile acids, suggest that low concentrations of
toxic bile acids, which might not reach the threshold required
to damage wild-type hepatocytes, could trigger the death of
IKK2-deficient cells. This increased sensitivity of IKK2-deficient
hepatocytes to bile acid toxicity could explain the spreading
of the damage and the severe liver disease in the Mdr2
2/2
IKK2
Hep-KO mice.
The original aim of our experiments was to address the role of
IKK2-mediated NF-kB activation in hepatocytes in HCC
development in Mdr2
2/2 mice, prompted by the study of
Pikarsky et al. [7] who showed that NF-kB inhibition in
hepatocytes by expression of an IkBa super-repressor could
prevent or delay HCC development in Mdr2-deficient mice. In
particular since IKK2
Hep-KO mice were shown to develop more
liver tumors than wild type mice in response to administration of
the chemical carcinogen diethylnitrosamine (DEN), we were
curious to test whether IKK2 deficiency would ameliorate or
aggravate HCC development in Mdr2
2/2 mice. However, we
found that hepatocyte-specific IKK2 ablation caused a severe
cholestatic liver disease already in very young Mdr2
2/2 mice
resulting in poor growth and early lethality, which prevented the
study of HCC development as the double knockout mice did not
live long enough to analyze tumor development. The oldest
Mdr2
2/2IKK2
Hep-KO mouse we obtained was 42 week old and
had no signs of HCC development. Moreover, histological
evaluation failed to reveal even the earliest premalignant lesions
that have been described to occur in the liver of Mdr2
2/2 mice at
Figure 4. Mdr2
2/2IKK2
Hep-KO mice develop severe fibrosis. (A) Representative images of Masson trichrome stained livers from 12-week-old
littermate male mice and from 27–30 week-old male mice. (B) Representative images of Sirius Red stained livers from 12-week-old littermate male
mice and from old adult male mice (27–30 weeks). Insert: High magnification of corresponding liver sections. Arrowhead: Pericellular fibers. Double
arrowhead: Pericellular space free of stained fibers. Genotypes as in (A). (C) Quantification of fibrosis in mice with the depicted genotypes measured
as percentage of Sirius Red positive area as a fraction of the total area of at least 10 high power fields per mouse. Left: young adult mice (males, 8–19
weeks), right: old adult mice (males, 20–42 weeks). Error bars indicate SEM. Scale bars, 100 mm.
doi:10.1371/journal.pone.0025942.g004
Role of IKK2 in Mdr2
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2/2IKK2
Hep-KO mice (data not
shown). However, histological examination of Mdr2
2/2 mice up
to 14 months of age failed to reveal any evidence of malignant or
premalignant lesions (data not shown). As the Mdr2
2/2 mice in
our colony were backcrossed for at least 4 generations in the
C57BL/6 genetic background, it is likely that the C57Bl/6 genetic
background prevents HCC development in these mice in contrast
to the FVB/N strain in which the malignant phenotype was
described [6]. The absence of tumors in our Mdr2
2/2 mice
(having more than 90% C57Bl/6 genetic background) is consistent
with the results of Klopstock et al, who observed strong reduction
in HCC development in Mdr2
2/2 mice having 75% FVB/N and
25% C57Bl/6 genetic background [20]. The C57Bl/6 genetic
background does not prevent HCC development only in the
Mdr2
2/2 but also in the HCV/ATX mouse model as first
described by Keasler et al. [27].
Curiously, Pikarsky et al. showed that NF-kB inhibition in
hepatocytes did not affect the early liver disease in Mdr2
2/2 mice
[7]. In contrast, our results presented here show that IKK2-
ablation strongly aggravated the liver pathology of Mdr2
2/2 mice
already at a very young age. This apparent discrepancy could be
due to the different genetic background of the animals, as our
studies were performed in mice backcrossed into the C57Bl/6
genetic background while Pikarsky et al. studied animals in the
FVB/N background. Alternatively, qualitative or quantitative
differences in the NF-kB inhibition achieved by the two different
models could also affect the phenotype. IKK2-ablation may have
a stronger inhibitory effect as compared to the expression of the
Figure 5. IKK2-deficient hepatocytes are more sensitive to bile acid induced apoptosis compared to wild type cells. (A) Representative
images of DAPI stained primary WT and IKK2-KO hepatocyte cultures. Cells were left untreated or were stimulated with taurolithocholic acid 3-sulfate
disodium salt (TLCS, 100 mM) for the indicated time periods. Arrowheads show apoptotic hepatocytes as indicated by smaller highly fluorescent
nuclei with condensed chromatin. Scale bars, 100 mm. (B) Graphs showing the average proportion of apoptotic hepatocytes from 3 independent
experiments. Mean values 6 SEM shown. * p,0,05; ** p,0,01; n.s.: not statistically significant. (C) Immunoblot detection of cleaved Caspase-3.
Primary hepatocytes were stimulated with glycochenodeoxy-cholate (GCDC, 50 mM, top) or TLCS (100 mM, bottom) for the indicated time periods.
Tubulin serves as loading control.
doi:10.1371/journal.pone.0025942.g005
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knockout prevents the nuclear translocation of a broader range of
NF-kB dimers compared to the IkBa-SR transgene, which
potently inhibits p50/p65 heterodimers but may be less efficient
to prevent nuclear translocation of other dimers. Finally, we
cannot exclude the possibility that additional non-NF-kB related
functions of IKK2 might also contribute to the observed
phenotype in Mdr2
2/2IKK2
Hep-KO mice. Further experiments
will be required to resolve the differential effect of IKK2 ablation
versus IkBa super-repressor expression in Mdr2
2/2 mice.
Interestingly, Mair et al. recently demonstrated that Mdr2
2/2
mice with liver parenchymal cell specific deficiency of STAT3
developed an aggravated liver disease compared to Mdr2
2/2
mice. Mdr2
2/2 mice lacking STAT3 or STAT5 in hepatocytes
strikingly resemble the phenotype of Mdr2
2/2IKK2
Hep-KO mice
[28,29]. In one study the absence of STAT3 rendered primary
hepatocytes more vulnerable to apoptosis induced by bile acids as
we have observed in our experiments with IKK2 deficient
hepatocytes [28]. Thus, NF-kB, STAT3 and STAT5 are
important to protect hepatocytes from bile acid toxicity and
prevent early liver damage in the Mdr2
2/2 genetic background.
In conclusion, our results revealed a previously unrecognized
essential function of IKK2-mediated signaling to protect hepato-
cytes from bile acid toxicity and prevent or ameliorate liver
damage under conditions of inflammatory biliary disease. Mice
lacking both Mdr2 and IKK2 in hepatocytes developed a severe
liver disease characterized by cholestasis, major hyperbilirubin-
emia and severe to end-stage fibrosis, which resulted in muscle
wasting, loss of body weight, lethargy and spontaneous death.
Thus, Mdr2
2/2IKK2
Hep-KO mice remarkably recapitulate chron-
ic liver failure in humans and might be of special importance for
the study of the mechanisms contributing to the pathogenesis of
end-stage chronic liver disease or its implications on other organs.
Materials and Methods
Animal experimentation
All animal procedures were conducted in accordance with
European (EU directive 86/609/EEC), national (TierSchG), and
institutional guidelines, and protocols and were approved by local
governmental authorities (Landesamt fu ¨r Natur, Umwelt und
Verbraucherschutz Nordrhein-Westfalen) under the license 8.87–
50.10.37.09.242.
The general health status of the mice was monitored regularly
and assessed by the following criteria: body weight, posture, signs of
pain, distress or discomfort and insufficient grooming. In order to
minimize suffering, mice were sacrificed when showing deteriora-
tionintheir general health.C57Bl/6 micecarrying loxP-siteflanked
ikk2 alleles (IKK2
FL) [16] were crossed to Albumin-Cre transgenic
mice [17] to obtain mice with a hepatocyte specific deletion of
IKK2 (IKK2
Hep-KO). IKK2
Hep-KO mice were crossed to Mdr2
2/2
mice to generate double knockout mice (Mdr2
2/2IKK2
Hep-KO),
miceheterozygousforMdr2carryingliver-specificdeletionofIKK2
(Mdr2
+/2IKK2
Hep-KO) and also Mdr2
2/2 mice carrying the IKK2
loxP-flanked alleles but not expressing Cre recombinase (Mdr2
2/2
IKK2
FL/FL, referred to as Mdr2
2/2 in the text and figures).
Genotyping
Genotyping-PCR was performed on DNA prepared from tail
biopsies of mice. The following primers were used for typing of
IKK2
floxed and Mdr2
2/2 and Mdr2
+/2 mice: Mdr2: 59-
CGGCGAGGATCTCGTCGTGACCCA-39,5 9-TGATGAAT-
ATTGGCGTTGTG-39,5 9-AATAGGGCAAACAGTCTACA-
G-39. IKK2: 59 - GTT CAG AGG TTC AGT CCA TTA TC
-3 9,5 9 - TAG CCT GCA AGA GAC AAT ACG - 39,5 9 - TCC
TCT CCT CGT CAT CCT TCG - 39. CRE: 59 – GTC CAA
TTT ACT GAC CGT ACA C - 39,5 9- CTG TCA CTT GGT
CGT GGC AGC - 39.
Histochemistry and Immunofluorescent Liver stainings
Hematoxylin/Eosin (HE), Masson’s trichrome and Sirius red
staining of liver sections were performed as recommended by the
manufacturer of the respective chemicals or staining kits (Sigma
Aldrich). Immunofluorescent detection of Cytokeratin 19 (CK19)
was performed on 10–12 mm thick freshly cut cryosections from
liver pieces previously kept on 280uC in tissue freezing medium
(Jung, Leica Microsystems Nussloch GmbH, Germany). After
fixation for 10 min in 4uC acetone and washing in PBS, sections
were incubated in blocking buffer (PBS, 3% BSA, 5% FCS) for
60 min. The sections were then incubated overnight at 4uC with
Cytokeratin 19 antibody (goat, Santa Cruz, 1:180 in blocking
solution). After washing, the secondary antibody (Alexa Fluor 594
donkey anti goat, molecular probes) was applied (1:1000 in PBS,
0.5% BSA) at room temperature for 60 minutes. After washing,
sections were incubated with DAPI and mounted with fluor-
omount. All images were analyzed and acquired on a Leica DM
5500 B microscope system.
TUNEL staining
Dying hepatocytes were detected by the terminal deoxynucleo-
tidyl transferase-mediated nick-end labeling (TUNEL) staining kit
according to the manufacturer’s instructions (Promega).
PCNA staining
Paraffin-embedded 5 mm sections were used for PCNA staining
after antigen retrieval by heating in citrate buffer [13]. The mouse
anti-PCNA antibody (Invitrogen) was used at a 1:200 dilution
followed by a goat anti-mouse secondary antibody coupled to
Alexa 594 (Molecular probes) at a 1:300 dilution. The samples
were visualized under a Zeiss LSM510 confocal microscope.
Biochemical analysis
Alanine aminotransferase, bilirubin and alkaline phosphatase
were measured on a Cobas chemical analyzer unit according to
the manufacturer (Roche Diagnostics, Mannheim, Germany).
Whole blood was collected by direct puncture of the heart and the
serum was obtained by 20-minute centrifugation at 13000 rpm..
The samples were diluted 1:6 (NaCl 0,9%) for measurements. The
results in graphs are depicted multiplied by 6.
Quantification of fibrotic area
The fibrotic area was measured by quantification of Sirius red
stained liver tissue relative to the section area. Therefore, at least
10 liver sections per mouse (at 1006magnification) from 2–3 liver
lobes were cut at 5 mm and stained with Sirius red. The imageJ
software was utilized to measure Sirius red positive tissue area.
Isolation of primary hepatocytes and cell culture
experiments
Anesthetized mice were perfused via the vena cava with solution
I (EBSS without Ca
2+ and Mg
2+, 0,5 mM EGTA). Subsequently,
perfusion with 50 ml of collagenase solution (EBSS with Ca
2+ and
Mg
2+, 10 mM Hepes, 3810 U collagenase and 2 mg Trypsin
inhibitor) was performed and single cell suspensions of perfused
liver were generated using a 70 mm nylon mesh. Hepatocytes were
washed twice in high glucose DMEM supplemented with 1% FCS.
2,5610
6 cells were seeded on collagen coated 10 cm dishes and
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day after plating for 2, 4 and 8 hours with hydrophobic bile acids.
Sodium glycochenodeoxy-cholate (Sigma G0759) was prepared as
10006Stock in DMSO and added to the hepatocytes in DMEM/
1% FCS to a final concentration of 50 mM. Taurolithocholic acid
3-sulfate disodium salt (Sigma T0512) was prepared as 10006
Stock in Methanol and added to the hepatocytes in DMEM/1%
FCS to a final concentration of 100 mM. For dead cell counts after
stimulation with bile acids primary hepatocytes were plated on
fibronectin (BD Bioscience) covered Menzel glasses in 6 well plates
and stimulated with taurolithocholic acid 3-sulfate disodium salt
(TLCS, Sigma) for the indicated time periods. Apoptotic nuclei
were identified by DAPI staining (as indicated by smaller highly
fluorescent nuclei with condensed chromatin) [25]. Three
independent experiments were performed and apoptotic/dead
and total number of cells were counted in 3 random non-
overlapping high power fields per timepoint. Unstimulated
primary hepatocytes were changed to fresh DMEM/1% FCS
medium and kept until the 48 h time point and then further
processed as the stimulated cells.
Immunoblot analysis
Cells were lysed with NP40 buffer supplemented with protease-
and phosphatase inhibitors (both Roche, Mannheim Germany).
56 SDS sample buffer was added, extracts were boiled for
10 minutes and run on standard 10% or 15% SDS polyacrylamid
gels. The following antibodies were used in this study: a-IKK2:
cell signaling #2684, 1:1000, a-cleaved caspase-3 (Asp175): cell
signaling, #9664, 1:1000, a-Tubulin: Sigma, #T6074, 1:1000,
Alkaline phosphatase conjugated anti-rabbit (NA934V) and anti-
mouse (NA9310V) antibodies were both from GE Healthcare and
were used 1:10.000 and 1:5000 respectively.
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